Results 31 to 40 of about 37,238 (263)

Basic and Translational Research on Proteinase-Activated Receptors: The Role of Thrombin Receptor in Cerebral Vasospasm in Subarachnoid Hemorrhage

open access: yesJournal of Pharmacological Sciences, 2008
Cerebral vasospasm is one of the major complications of subarachnoid hemorrhage (SAH). The prevention and treatment of cerebral vasospasm thus plays a critical role in the management of SAH patients.
Yasutoshi Kai   +4 more
doaj   +1 more source

Symptomatic Cerebral Vasospasm after Surgical Ligation of Unruptured Aneurysms [PDF]

open access: yes, 2009
Background Cerebral artery vasospasm accounts for the majority of delayed neurological deficits in ruptured aneurysm patients. We report two cases and review the literature of patients who developed symptomatic vasospasm after treatment for unruptured ...
Harrop, James, MD   +1 more
core   +2 more sources

Ventral Intramedullary Cervical Spinal Cord AVM [PDF]

open access: yes, 2009
Background Cerebral artery vasospasm accounts for the majority of delayed neurological deficits in ruptured aneurysm patients. We report two cases and review the literature of patients who developed symptomatic vasospasm after treatment for unruptured ...
Jabbour, Pascal, MD   +2 more
core   +2 more sources

Pathogenic mechanisms and therapeutic implications of extracellular matrix remodelling in cerebral vasospasm

open access: yesFluids and Barriers of the CNS, 2023
Cerebral vasospasm significantly contributes to poor prognosis and mortality in patients with aneurysmal subarachnoid hemorrhage. Current research indicates that the pathological and physiological mechanisms of cerebral vasospasm may be attributed to the
Ziliang Hu   +6 more
doaj   +1 more source

Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]) [PDF]

open access: yes, 2016
BACKGROUND AND PURPOSE—: We conducted a randomized, open-label, phase 1/2a, dose-escalation study of intraventricular sustained-release nimodipine (EG-1962) to determine safety, tolerability, pharmacokinetics, and clinical effects in aneurysmal ...
Aldrich, Francois   +10 more
core   +3 more sources

Intra‐arterial infusion of fasudil hydrochloride to treat post‐traumatic cerebral vasospasm

open access: yesAcute Medicine & Surgery, 2019
Background The effect of intra‐arterial infusion of fasudil hydrochloride in patients with post‐traumatic cerebral vasospasm remains unclear. Here we report a case of intra‐arterial infusion of fasudil hydrochloride for post‐traumatic cerebral vasospasm.
Tomoaki Murakami   +8 more
doaj   +1 more source

Can S100B predict cerebral vasospasms in patients suffering from subarachnoid hemorrhage?

open access: yesFrontiers in Neurology, 2013
Background: Protein S100B has proven to be a useful biomarker for cerebral damages. Increased levels of serum and CSF S100B have been shown in patients suffering subarachnoid hemorrhage, severe head injury and stroke.
Moshgan eAmiri   +3 more
doaj   +1 more source

Minimal long-term neurobehavioral impairments after endovascular perforation subarachnoid hemorrhage in mice [PDF]

open access: yes, 2017
Cognitive deficits are among the most severe and pervasive consequences of aneurysmal subarachnoid hemorrhage (SAH). A critical step in developing therapies targeting such outcomes is the characterization of experimentally-tractable pre-clinical models ...
Brody, David L   +5 more
core   +2 more sources

ERYTHROPOIETIN FOR THE TREATMENT OF SUBARACHNOID HEMORRAGE: A FEASIBLE INGREDIENT FOR A SUCCESS MEDICAL RECIPE [PDF]

open access: yes, 2015
Subaracnhoid hemorrage (SAH) following aneurysm bleeding accounts for 6% to 8% of all cerebrovascular accidents. Althoug an aneurysm can be effectively managed by surgery or endovascular therapy, delayed cerebral ischemia is diagnosed in a high ...
A Gorio   +101 more
core   +1 more source

Home - About - Disclaimer - Privacy